Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

AutoFocus360 Sound Quality Preference and Claims Study

NCT: NCT07224919 · COMPLETED

NCT IDNCT07224919
StatusCOMPLETED
Start Date2025-11-27
Completion2026-03-19

Brief Summary

This study aims to generate clinical evidence to substantiate performance claims for the AutoFocus 360 feature in Sonova hearing aid products. AutoFocus 360 is designed to enhance speech intelligibility by detecting the direction of incoming speech and dynamically steering the beamformer toward the talker, regardless of their position relative to the listener. Preliminary internal testing suggested potential benefits in reducing noise disturbance and improving speech clarity compared to traditional directional microphone modes, with outcomes depending on noise type, talker location, and microphone configuration. The present study will systematically evaluate sound quality and listening performance with AutoFocus 360 versus conventional fixed directional settings to support claims of improved speech understanding in noise.

Frequently Asked Questions

What is AutoFocus360 Sound Quality Preference and Claims Study?

AutoFocus360 Sound Quality Preference and Claims Study is a clinical trial registered under NCT07224919. Current status: COMPLETED.

What is the status of NCT07224919?

The current status of NCT07224919 (AutoFocus360 Sound Quality Preference and Claims Study) is: COMPLETED.

When did AutoFocus360 Sound Quality Preference and Claims Study start?

AutoFocus360 Sound Quality Preference and Claims Study started on 2025-11-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.